VISEN Pharmaceuticals (HKG:2561)

VISEN Pharmaceuticals Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	242.65	347.78	626.46
Cash & Short-Term Investments	242.65	347.78	626.46
Cash Growth	-	-44.48%	-
Other Receivables	2.46	4.09	1.45
Receivables	2.46	4.09	1.45
Other Current Assets	23.85	22.25	83.69
Total Current Assets	268.96	374.12	711.59
Property, Plant & Equipment	11.89	13.26	17.16
Other Intangible Assets	0.07	0.57	1.42
Other Long-Term Assets	58.01	55.85	11.1
Total Assets	338.94	443.8	741.27
Accounts Payable	6.28	1.01	27.98
Accrued Expenses	25.3	29.85	25.48
Current Portion of Leases	2.39	2.55	4.67
Current Income Taxes Payable	0.67	1.85	2.57
Current Unearned Revenue	-	2.9	2.9
Other Current Liabilities	14.1	13.67	23.74
Total Current Liabilities	48.74	51.82	87.34
Long-Term Leases	0.6	1.1	1.33
Total Liabilities	49.34	52.92	88.67
Common Stock	0.07	0.07	0.07
Additional Paid-In Capital	1,523	1,523	1,523
Retained Earnings	-1,561	-1,431	-1,182
Treasury Stock	-0.01	-0.01	-0.01
Comprehensive Income & Other	327.13	298.91	311.07
Shareholders' Equity	289.6	390.88	652.61
Total Liabilities & Equity	338.94	443.8	741.27
Total Debt	2.99	3.65	6
Net Cash (Debt)	239.66	344.13	620.46
Net Cash Growth	-	-44.54%	-
Net Cash Per Share	25.66	36.84	-
Filing Date Shares Outstanding	9.34	9.34	-
Total Common Shares Outstanding	9.34	9.34	-
Working Capital	220.22	322.3	624.25
Book Value Per Share	31.00	41.85	-
Tangible Book Value	289.53	390.31	651.19
Tangible Book Value Per Share	31.00	41.79	-
Machinery	1.56	1.53	1.59
Leasehold Improvements	0.28	1.76	3.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.